Factors affecting Discontinuation of the Once-a-month Injectable Contraceptive (Cyclofem) in Neyshabur, Iran

Background & aim: The developing countries have the contraceptive prevalence rate of 43%. Contraceptive discontinuation accounts for a large number of unintended pregnancies in these countries. The present study aimed to investigate the factors associated with Cyclofem discontinuation. Methods:...

Full description

Bibliographic Details
Main Authors: Mansoore shariati, Azar Golmakany, Parviz Maroozi, Bahar Bayati
Format: Article
Language:English
Published: Mashhad University of Medical Sciences 2018-04-01
Series:Journal of Midwifery & Reproductive Health
Subjects:
Online Access:http://jmrh.mums.ac.ir/article_10474_68a0e4e46ad7561f70e8a5c57f027208.pdf
id doaj-c8522fb8fbe34e09a58f0ee8de271b1e
record_format Article
spelling doaj-c8522fb8fbe34e09a58f0ee8de271b1e2020-11-24T22:39:23ZengMashhad University of Medical SciencesJournal of Midwifery & Reproductive Health 2345-47922345-47922018-04-01621244125210.22038/jmrh.2018.1047410474Factors affecting Discontinuation of the Once-a-month Injectable Contraceptive (Cyclofem) in Neyshabur, IranMansoore shariati0Azar Golmakany1Parviz Maroozi2Bahar Bayati3Lecturer, Department of Midwifery, Neyshabur Branch, Islamic Azad University, Neyshabur, IranLecturer, Department of Midwifery, Neyshabur Branch, Islamic Azad University, Neyshabur, IranLecturer, Department of Epidemiology and Biostatistics, Mashhad University of Medical Sciences, Mashhad, IranLecturer, Department of Epidemiology and Biostatistics, Mashhad University of Medical Sciences, Mashhad, IranBackground & aim: The developing countries have the contraceptive prevalence rate of 43%. Contraceptive discontinuation accounts for a large number of unintended pregnancies in these countries. The present study aimed to investigate the factors associated with Cyclofem discontinuation. Methods: This historical cohort study was conducted on 198 females, selected through cluster and Poisson sampling techniques. The first dose of Cyclofem was administered one month prior to the research. The data were collected using a questionnaire filled out through interviewing. Results: During the study period, only 3.94% of the health centers clients selected Cyclofem as a contraceptive method. The mean duration of Cyclofem use was 7.1±8.01 months. The likelihood of contraceptive continuation declined with increased consumption duration. Menstrual complications caused by this contraceptive method included irregular menstruation (35.4%) and neurological problems (14.6%). Furthermore, there were some personal reasons (8.1%) accounting for the discontinuation of this method. The frequency of Cyclofem use decreased with increased rate of menstrual irregularities (P=0.045) and spotting (P=0.020). Based on the participants’ reports, the most frequent complications were the medical ones. However, there was no significant difference between the females who continued Cyclofem use and those who discontinued (P=0.08). The majority of the participants reported no particular non-medical problems. The results revealed that the participants who used Cyclofem for a longer time stopped using this birth control method less commonly than those used it for a shorter time (Phttp://jmrh.mums.ac.ir/article_10474_68a0e4e46ad7561f70e8a5c57f027208.pdfInjectable ContraceptionCyclofemDiscontinuationSide effects
collection DOAJ
language English
format Article
sources DOAJ
author Mansoore shariati
Azar Golmakany
Parviz Maroozi
Bahar Bayati
spellingShingle Mansoore shariati
Azar Golmakany
Parviz Maroozi
Bahar Bayati
Factors affecting Discontinuation of the Once-a-month Injectable Contraceptive (Cyclofem) in Neyshabur, Iran
Journal of Midwifery & Reproductive Health
Injectable Contraception
Cyclofem
Discontinuation
Side effects
author_facet Mansoore shariati
Azar Golmakany
Parviz Maroozi
Bahar Bayati
author_sort Mansoore shariati
title Factors affecting Discontinuation of the Once-a-month Injectable Contraceptive (Cyclofem) in Neyshabur, Iran
title_short Factors affecting Discontinuation of the Once-a-month Injectable Contraceptive (Cyclofem) in Neyshabur, Iran
title_full Factors affecting Discontinuation of the Once-a-month Injectable Contraceptive (Cyclofem) in Neyshabur, Iran
title_fullStr Factors affecting Discontinuation of the Once-a-month Injectable Contraceptive (Cyclofem) in Neyshabur, Iran
title_full_unstemmed Factors affecting Discontinuation of the Once-a-month Injectable Contraceptive (Cyclofem) in Neyshabur, Iran
title_sort factors affecting discontinuation of the once-a-month injectable contraceptive (cyclofem) in neyshabur, iran
publisher Mashhad University of Medical Sciences
series Journal of Midwifery & Reproductive Health
issn 2345-4792
2345-4792
publishDate 2018-04-01
description Background & aim: The developing countries have the contraceptive prevalence rate of 43%. Contraceptive discontinuation accounts for a large number of unintended pregnancies in these countries. The present study aimed to investigate the factors associated with Cyclofem discontinuation. Methods: This historical cohort study was conducted on 198 females, selected through cluster and Poisson sampling techniques. The first dose of Cyclofem was administered one month prior to the research. The data were collected using a questionnaire filled out through interviewing. Results: During the study period, only 3.94% of the health centers clients selected Cyclofem as a contraceptive method. The mean duration of Cyclofem use was 7.1±8.01 months. The likelihood of contraceptive continuation declined with increased consumption duration. Menstrual complications caused by this contraceptive method included irregular menstruation (35.4%) and neurological problems (14.6%). Furthermore, there were some personal reasons (8.1%) accounting for the discontinuation of this method. The frequency of Cyclofem use decreased with increased rate of menstrual irregularities (P=0.045) and spotting (P=0.020). Based on the participants’ reports, the most frequent complications were the medical ones. However, there was no significant difference between the females who continued Cyclofem use and those who discontinued (P=0.08). The majority of the participants reported no particular non-medical problems. The results revealed that the participants who used Cyclofem for a longer time stopped using this birth control method less commonly than those used it for a shorter time (P
topic Injectable Contraception
Cyclofem
Discontinuation
Side effects
url http://jmrh.mums.ac.ir/article_10474_68a0e4e46ad7561f70e8a5c57f027208.pdf
work_keys_str_mv AT mansooreshariati factorsaffectingdiscontinuationoftheonceamonthinjectablecontraceptivecyclofeminneyshaburiran
AT azargolmakany factorsaffectingdiscontinuationoftheonceamonthinjectablecontraceptivecyclofeminneyshaburiran
AT parvizmaroozi factorsaffectingdiscontinuationoftheonceamonthinjectablecontraceptivecyclofeminneyshaburiran
AT baharbayati factorsaffectingdiscontinuationoftheonceamonthinjectablecontraceptivecyclofeminneyshaburiran
_version_ 1725709148499214336